Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Tuberous Sclerosis 6Seizures 5Marijuana Abuse 3Lennox Gastaut Syndrome 3Epilepsies, Myoclonic 3Colonic Neoplasms 3Breast Neoplasms 3Sturge-Weber Syndrome 2Neoplasms 2Nausea 2Glioblastoma 2Anxiety Disorders 2Vomiting 1Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Spasms, Infantile 1Solid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Parasomnias 1Pancreatic Neoplasms 1Pain 1Multiple Myeloma 1Liver Neoplasms 1Liver Cirrhosis 1Gallbladder Neoplasms 1Epilepsy 1Dysgeusia 1Drug Resistant Epilepsy 1Colorectal Neoplasms 1

Interventions

Music Therapy 15Therapeutics 14Surveys and Questionnaires 13Cognitive Behavioral Therapy 13Psychiatric Rehabilitation 12Methods 9Standard of Care 8Educational Status 8Early Intervention, Educational 8Psilocybin 7Mindfulness 6Ketamine 6Hypnosis 6Control Groups 6Aromatherapy 6Acupuncture Therapy 6Mindfulness-Based Stress Reduction 5Mindfulness-Based Cognitive Therapy 5Massage 5Counseling 5Art Therapy 5Saline Solution 4Interviews as Topic 4Imagery, Psychotherapy 4Esketamine 4Caregivers 4Behavior Therapy 4Autogenic Training 4Yoga 3Weights and Measures 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anxiety Disorders × Cannabidiol × Clear all
NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed
91 enrolled

Anxiety Disorders, Nausea, Pain, Parasomnias

NCT04482244 2025-07-29

RCT of CBD for Anxiety in Advanced Breast Cancer

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
60 enrolled 11 charts

Anxiety Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡